Results 161 to 170 of about 209,409 (314)

Assessment of Venous Thromboembolism Risk Among Patients Admitted to Intensive Care Units in Dhaka City: A Cross-Sectional Study. [PDF]

Public Health Chall
Khan MSS, Parves MM, Noman AA, Gupta PKS, Rahman MM, Tanjim KF, Khatun M, Chowdhury MJ, Rahman KA, Rahman AKMF, Islam MS.   +10 more
europepmc   +1 more source

Pregnancy Outcomes Among Individuals With Cerebral Palsy: A Population‐Based Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To examine the risks of maternal, neonatal and non‐obstetrical medical complications in individuals with cerebral palsy (CP) compared to those without CP. Design Population‐based cohort study. Setting Ontario, Canada. Population Females aged 13–54 years with a livebirth or stillbirth, 2004–2023.
Marina Vainder, Anne Berndl, Aditi Patrikar, Hilary K. Brown   +3 more
wiley   +1 more source

Pulmonary Thromboembolism in a Patient With Behçet's Disease: A Case Report. [PDF]

Case Rep Med
Kalantari E, Emami Ardestani M.
europepmc   +1 more source

Predictors of reduced length of stay in minimally invasive colectomy, a 20‐year study

Surgical Practice, EarlyView.
Abstract Purpose Minimally invasive colorectal resection is a common surgical procedure indicated for a variety of malignant and benign conditions. Length of stay (los) is an important metric in the evaluation of surgical care quality and healthcare expenditure.
Elisa Tran, Angel Hayes, Amy Cao, Andrew Stevenson, David Clark   +4 more
wiley   +1 more source

Unprovoked Venous Thromboembolism in a Patient with a Small PNH Clone: A Therapeutic Dilemma. [PDF]

J Brown Hosp Med
Balusu K, Malipeddi D, Phatak P.
europepmc   +1 more source

Asymptomatic Hypertrophic Cardiomyopathy: Diagnosis and Therapy [PDF]

, 2017
Fuentes, V L, Wilkie, L J
core   +1 more source

Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan, Angela Hwang, Nicole Wong Doo, Tracy King, Christian Bryant, Jennifer Zhang, Kristina Whelan, Parisa Fani‐Molky, Giselle Kidson‐Gerber, Annmarie Bosco, Nada Hamad, Gurdeep Parmar, Fiona Kwok, Sam Lai, Silvia Ling, P. Joy Ho, Georgia McCaughan, Adam Bryant   +17 more
wiley   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Targeting Immunologic Pathways in Eosinophilic Granulomatosis With Polyangiitis: Translating Emerging Evidence Into Clinical Practice

Allergy, EarlyView.
ABSTRACT Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare and potentially life‐threatening systemic, inflammatory disease with multi‐organ manifestations, variable presentation and complex pathology. Multiple interconnected immunological pathways are implicated in EGPA pathology, including a type‐2 immune response driving predominantly ...
Harold Wilson‐Morkeh, Lior Seluk, Philipp Bosch, Carolina Aguiar, Jens Thiel, Bernhard Hellmich, Michael E. Wechsler, Salman Siddiqui   +7 more
wiley   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source